carnitine deficiency-associated gene expressed in ventricle 3
Description:
FOUND IN cytoplasm; cytosol (ortholog); plasma membrane (ortholog); INTERACTS WITH 17alpha-ethynylestradiol; 2,3,7,8-tetrachlorodibenzodioxine; 4-hydroxyphenyl retinamide
2510010F10Rik; C230084J24Rik; C79446; carnitine deficiency-associated protein 3; carnitine deficiency-associated protein CDV3A; carnitine deficiency-associated protein CDV3B; TPP36; tyrosine-phosphorylated protein 36
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDV3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDV3 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDV3 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDV3 mRNA
[Clofibrate co-treated with Acetaminophen] affects the expression of CDV3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CDV3 mRNA]
MT1 affects the reaction [Copper results in increased expression of CDV3 mRNA], MT2 affects the reaction [Copper results in increased expression of CDV3 mRNA]
MT1 affects the reaction [Copper results in increased expression of CDV3 mRNA], MT2 affects the reaction [Copper results in increased expression of CDV3 mRNA]
MT1 affects the reaction [Copper results in increased expression of CDV3 mRNA], MT2 affects the reaction [Copper results in increased expression of CDV3 mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDV3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDV3 mRNA
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDV3 mRNA
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDV3 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDV3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDV3 mRNA
[Clofibrate co-treated with Acetaminophen] affects the expression of CDV3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CDV3 mRNA]
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDV3 mRNA
Gene Ontology Annotations
